Apyx Medical Corp Other Expenses
Apyx Medical Corp (APYX) reported Other Expenses of $9.53 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherExpenses · last filed 2026-08-06
- Apyx Medical Corp other expenses for the quarter ending 2026-06-30 was $9.53M, a 9.47% increase year-over-year.
- Apyx Medical Corp other expenses for the quarter ending 2026-03-31 was $7.77M, a 1.36% decline year-over-year.
- Apyx Medical Corp other expenses for the quarter ending 2025-12-31 was $9.97M, a 4.46% decline year-over-year.
- Apyx Medical Corp other expenses for the quarter ending 2025-09-30 was $7.87M, a 16.74% decline year-over-year.
- Apyx Medical Corp other expenses for fiscal 2025 was $34.43M, a 21.14% decline from fiscal 2024.
- Apyx Medical Corp other expenses for fiscal 2024 was $43.66M, a 7.49% decline from fiscal 2023.
- Apyx Medical Corp other expenses for fiscal 2023 was $47.20M.
| Period end | Other Expenses 3 month | Other Expenses 6 month | Other Expenses 9 month | Other Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.53M 10-Q · filed 2026-08-06 | $17.30M 10-Q · filed 2026-08-06 | $27.27M derived: sum of 3 quarters · filed 2026-08-06 | $35.15M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $7.77M 10-Q · filed 2026-05-07 | $17.74M derived: sum of 2 quarters · filed 2026-05-07 | $25.62M derived: sum of 3 quarters · filed 2026-05-07 | $34.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $9.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $17.85M derived: sum of 2 quarters · filed 2026-03-10 | $26.55M derived: sum of 3 quarters · filed 2026-08-06 | $34.43M 10-K · filed 2026-03-10 |
| 2025-09-30 | $7.87M 10-Q · filed 2025-11-06 | $16.58M derived: sum of 2 quarters · filed 2026-08-06 | $24.46M 10-Q · filed 2025-11-06 | $34.89M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $8.71M 10-Q · filed 2026-08-06 | $16.58M 10-Q · filed 2026-08-06 | $27.02M derived: sum of 3 quarters · filed 2026-08-06 | $36.48M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $7.88M 10-Q · filed 2026-05-07 | $18.32M derived: sum of 2 quarters · filed 2026-05-07 | $27.77M derived: sum of 3 quarters · filed 2026-05-07 | $39.69M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $10.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $19.89M derived: sum of 2 quarters · filed 2026-03-10 | $31.81M derived: sum of 3 quarters · filed 2026-03-10 | $43.66M 10-K · filed 2026-03-10 |
| 2024-09-30 | $9.46M 10-Q · filed 2025-11-06 | $21.37M derived: sum of 2 quarters · filed 2025-11-06 | $33.22M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $11.92M 10-Q · filed 2025-08-07 | $23.76M 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $11.85M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $47.20M 10-K · filed 2025-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |